SICM
AZN icon

Sustainable Insight Capital Management’s AstraZeneca AZN Stock Holding History

Sustainable Insight Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,600
Closed -$222K – 58
2023
Q1 		$222K Buy
+1,600
New +$215K 0.22% 77

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sustainable Insight Capital Management's AZN Position: Q2 2023 in Review

Sustainable Insight Capital Management sold out of AstraZeneca (AZN) in Q2 2023, closing a stake of 1,600 shares — an estimated $222K sold.

Sustainable Insight Capital Management first reported a position in AZN in Q1 2023 and held it in 1 quarter. The position peaked at $222K in Q1 2023. 1,092 funds tracked by Wall St. Rank hold AZN as of Q2 2023.

  • Sustainable Insight Capital Management reported no remaining AstraZeneca position as of Q2 2023 after selling out during the quarter.
  • Sustainable Insight Capital Management sold 1,600 AstraZeneca shares in Q2 2023, an estimated $222K.
  • Sustainable Insight Capital Management first reported a position in AstraZeneca in Q1 2023 and held it in 1 quarter.
  • Sustainable Insight Capital Management's AstraZeneca position peaked at $222K in Q1 2023.
  • 1,092 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2023.

Based on Sustainable Insight Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.